{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T06:57:24Z","timestamp":1781765844927,"version":"3.54.5"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,3]],"date-time":"2021-11-03T00:00:00Z","timestamp":1635897600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010096","name":"Southern Medical University","doi-asserted-by":"publisher","award":["202012121010"],"award-info":[{"award-number":["202012121010"]}],"id":[{"id":"10.13039\/501100010096","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010096","name":"Southern Medical University","doi-asserted-by":"publisher","award":["S202112121123"],"award-info":[{"award-number":["S202112121123"]}],"id":[{"id":"10.13039\/501100010096","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000051","name":"National Human Genome Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000051","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.biopha.2021.112407","type":"journal-article","created":{"date-parts":[[2021,11,12]],"date-time":"2021-11-12T18:41:50Z","timestamp":1636742510000},"page":"112407","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Trans-eQTLs of the CYP3A4 and CYP3A5 associated with tacrolimus trough blood concentration in Chinese renal transplant patients"],"prefix":"10.1016","volume":"145","author":[{"given":"Huijie","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haixia","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengcheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanjiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruifan","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daoyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huana","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinuan","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojie","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2021.112407_bib1","doi-asserted-by":"crossref","first-page":"585","DOI":"10.2217\/14622416.9.5.585","article-title":"Pharmacogenetics of immunosuppressive drugs: prospect of individual therapy for transplant patients","volume":"9","author":"Ekbal","year":"2008","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.biopha.2021.112407_bib2","doi-asserted-by":"crossref","first-page":"68","DOI":"10.12659\/AOT.889858","article-title":"Effect of different tacrolimus levels on early outcomes after kidney transplantation","volume":"19","author":"Rehman","year":"2014","journal-title":"Ann. Transpl."},{"key":"10.1016\/j.biopha.2021.112407_bib3","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1097\/01.TP.0000174131.47469.D2","article-title":"Sirolimus and tacrolimus trough concentrations and dose requirements after kidney transplantation in relation to CYP3A5 and MDR1 polymorphisms and steroids","volume":"80","author":"Mourad","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.biopha.2021.112407_bib4","doi-asserted-by":"crossref","first-page":"328","DOI":"10.2133\/dmpk.22.328","article-title":"Metabolism of tacrolimus (FK506) and recent topics in clinical pharmacokinetics","volume":"22","author":"Iwasaki","year":"2007","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.biopha.2021.112407_bib5","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s00204-008-0332-8","article-title":"Inhibition and induction of human cytochrome P450 enzymes: current status","volume":"82","author":"Pelkonen","year":"2008","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.biopha.2021.112407_bib6","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1124\/dmd.114.057000","article-title":"Relative contributions of cytochrome CYP3A4 versus CYP3A5 for CYP3A-cleared drugs assessed in vitro using a CYP3A4-selective inactivator (CYP3cide)","volume":"42","author":"Tseng","year":"2014","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.biopha.2021.112407_bib7","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1016\/j.clinthera.2013.08.019","article-title":"Personalized tacrolimus doses determined by CYP3A5 genotype for induction and maintenance phases of kidney transplantation","volume":"35","author":"Vannaprasaht","year":"2013","journal-title":"Clin. Ther."},{"key":"10.1016\/j.biopha.2021.112407_bib8","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/tpj.2017.49","article-title":"Genome-wide association study identifies the common variants in CYP3A4 and CYP3A5 responsible for variation in tacrolimus trough concentration in Caucasian kidney transplant recipients","volume":"18","author":"Oetting","year":"2018","journal-title":"Pharmacogenom. J."},{"key":"10.1016\/j.biopha.2021.112407_bib9","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/bcpt.13016","article-title":"CYP3A5*3 and ABCB1 61A>G significantly influence dose-adjusted trough blood tacrolimus concentrations in the first three months post-kidney transplantation","volume":"123","author":"Hu","year":"2018","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.biopha.2021.112407_bib10","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.transproceed.2005.01.077","article-title":"Genetic polymorphisms of CYP3A5 genes and concentration of the cyclosporine and tacrolimus","volume":"37","author":"Zhao","year":"2005","journal-title":"Transpl. Proc."},{"key":"10.1016\/j.biopha.2021.112407_bib11","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/j.transproceed.2009.01.097","article-title":"Effect of CYP3A5 genotype on renal allograft recipients treated with tacrolimus","volume":"41","author":"Chen","year":"2009","journal-title":"Transpl. Proc."},{"key":"10.1016\/j.biopha.2021.112407_bib12","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/s41397-021-00216-w","article-title":"Functional CYP3A variants affecting tacrolimus trough blood concentrations in Chinese renal transplant recipients","volume":"21","author":"Chen","year":"2021","journal-title":"Pharmacogenom. J."},{"key":"10.1016\/j.biopha.2021.112407_bib13","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.2217\/pgs.15.78","article-title":"Interactive effects of CYP3A4, CYP3A5, MDR1 and NR1I2 polymorphisms on tracrolimus trough concentrations in early postrenal transplant recipients","volume":"16","author":"Li","year":"2015","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.biopha.2021.112407_bib14","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1021\/mp500590s","article-title":"The functional implications of common genetic variation in CYP3A5 and ABCB1 in human proximal tubule cells","volume":"12","author":"Knops","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.biopha.2021.112407_bib15","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1081\/DMR-46136","article-title":"Regulation of cytochrome P450 by posttranslational modification","volume":"37","author":"Aguiar","year":"2005","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.biopha.2021.112407_bib16","doi-asserted-by":"crossref","first-page":"14","DOI":"10.2133\/dmpk.23.14","article-title":"Interplay of pregnane X receptor with other nuclear receptors on gene regulation","volume":"23","author":"Lim","year":"2008","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.biopha.2021.112407_bib17","doi-asserted-by":"crossref","first-page":"528","DOI":"10.3389\/fgene.2019.00528","article-title":"Genome-wide association study of tacrolimus pharmacokinetics identifies novel single nucleotide polymorphisms in the convalescence and stabilization periods of post-transplant liver function","volume":"10","author":"Liu","year":"2019","journal-title":"Front. Genet."},{"issue":"1","key":"10.1016\/j.biopha.2021.112407_bib18","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/FTD.0b013e31829da6dd","article-title":"Impact of POR*28 on the pharmacokinetics of tacrolimus and cyclosporine A in renal transplant patients","volume":"36","author":"Elens","year":"2014","journal-title":"Ther. Drug Monit."},{"issue":"9","key":"10.1016\/j.biopha.2021.112407_bib19","doi-asserted-by":"crossref","first-page":"728","DOI":"10.5414\/CP202152","article-title":"The genetic polymorphisms of POR*28 and CYP3A5*3 significantly influence the pharmacokinetics of tacrolimus in Chinese renal transplant recipients","volume":"53","author":"Zhang","year":"2015","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"issue":"6","key":"10.1016\/j.biopha.2021.112407_bib20","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1038\/clpt.2011.336","article-title":"PPARA: a novel genetic determinant of CYP3A4 in vitro and in vivo","volume":"91","author":"Klein","year":"2012","journal-title":"Clin. Pharmacol. Ther."},{"issue":"6","key":"10.1016\/j.biopha.2021.112407_bib21","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s00228-014-1656-3","article-title":"The influence of CYP3A, PPARA, and POR genetic variants on the pharmacokinetics of tacrolimus and cyclosporine in renal transplant recipients","volume":"70","author":"Lunde","year":"2014","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"12","key":"10.1016\/j.biopha.2021.112407_bib22","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.2174\/1389200218666170531112038","article-title":"Differential regulation of CYP3A4 and CYP3A5 and its implication in drug discovery","volume":"18","author":"Lolodi","year":"2017","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.biopha.2021.112407_bib23","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1124\/mol.119.116897","article-title":"Ligand-free estrogen receptor alpha (ESR1) as master regulator for the expression of CYP3A4 and other cytochrome P450 enzymes in the human liver","volume":"96","author":"Wang","year":"2019","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.biopha.2021.112407_bib24","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1124\/jpet.109.160804","article-title":"Genetic predictors of interindividual variability in hepatic CYP3A4 expression","volume":"332","author":"Lamba","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.biopha.2021.112407_bib25","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1101\/gr.103341.109","article-title":"Systematic genetic and genomic analysis of cytochrome P450 enzyme activities in human liver","volume":"20","author":"Yang","year":"2010","journal-title":"Genome Res."},{"issue":"6","key":"10.1016\/j.biopha.2021.112407_bib26","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1111\/bcp.13908","article-title":"Activity and mRNA expression levels of selected cytochromes P450 in various sections of the human small intestine","volume":"85","author":"Clermont","year":"2019","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.biopha.2021.112407_bib27","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nature24277","article-title":"Genetic effects on gene expression across human tissues","volume":"550","author":"Consortium","year":"2017","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.biopha.2021.112407_bib28","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1101\/gr.216754.116","article-title":"Identifying cis-mediators for trans-eQTLs across many human tissues using genomic mediation analysis","volume":"27","author":"Yang","year":"2017","journal-title":"Genome Res."},{"issue":"Suppl 3","key":"10.1016\/j.biopha.2021.112407_bib29","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s12859-019-2651-6","article-title":"Identification of trans-eQTLs using mediation analysis with multiple mediators","volume":"20","author":"Shan","year":"2019","journal-title":"BMC Bioinform."},{"key":"10.1016\/j.biopha.2021.112407_bib30","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1002\/cpt.1751","article-title":"A new liver expression quantitative trait locus map from 1,183 individuals provides evidence for novel expression quantitative trait loci of drug response, metabolic, and sex-biased phenotypes","volume":"107","author":"Etheridge","year":"2020","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.biopha.2021.112407_bib31","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1126\/science.aaz1776","article-title":"The GTEx Consortium atlas of genetic regulatory effects across human tissues","volume":"369","author":"Consortium","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.biopha.2021.112407_bib32","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s00228-011-1010-y","article-title":"Tacrolimus dosing in Chinese renal transplant recipients: a population-based pharmacogenetics study","volume":"67","author":"Li","year":"2011","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.biopha.2021.112407_bib33","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1093\/bioinformatics\/btm025","article-title":"SNPassoc: an R package to perform whole genome association studies","volume":"23","author":"Gonz\u00e1lez","year":"2007","journal-title":"Bioinformatics"},{"key":"10.1016\/j.biopha.2021.112407_bib34","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/phar.2204","article-title":"TLR9 rs352139 genetic variant promotes tacrolimus elimination in Chinese liver transplant patients during the early posttransplantation period","volume":"39","author":"Ou","year":"2019","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.biopha.2021.112407_bib35","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1111\/liv.13597","article-title":"Association of donor small ubiquitin-like modifier 4 rs237025 genetic variant with tacrolimus elimination in the early period after liver transplantation","volume":"38","author":"Zhang","year":"2018","journal-title":"Liver Int."},{"key":"10.1016\/j.biopha.2021.112407_bib36","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2133\/dmpk.DMPK-13-RG-095","article-title":"Association of hemoglobin levels, CYP3A5, and NR1I3 gene polymorphisms with tacrolimus pharmacokinetics in liver transplant patients","volume":"29","author":"Chen","year":"2014","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.biopha.2021.112407_bib37","doi-asserted-by":"crossref","first-page":"53","DOI":"10.15403\/jgld-158","article-title":"Cirrhosis risk score of the donor organ predicts early fibrosis progression after liver transplantation","volume":"28","author":"Zimmermann","year":"2019","journal-title":"J. Gastrointest. Liver Dis."},{"key":"10.1016\/j.biopha.2021.112407_bib38","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1089\/gtmb.2016.0062","article-title":"Risk factors for hepatocellular carcinoma in cirrhotic patients with chronic hepatitis B","volume":"20","author":"Zhang","year":"2016","journal-title":"Genet. Test. Mol. Biomark."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221011938?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221011938?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T06:29:35Z","timestamp":1781764175000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332221011938"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":38,"alternative-id":["S0753332221011938"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2021.112407","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trans-eQTLs of the CYP3A4 and CYP3A5 associated with tacrolimus trough blood concentration in Chinese renal transplant patients","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2021.112407","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"112407"}}